BridgeMD
New treatment option for Stroke
Official title Stimulating Postural Control to Augment Rehabilitation After Cerebral Stroke (SPARC): a Pilot Trial
ClinicalTrials.gov ID: NCT06987682
What this study is testing
- What it's testing
- People living with stroke have a high risk of falling and this risk increases as mobility improves over the first year post-stroke. Despite the high number of falls, there is a lack of interventions to prevent falls after stroke.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 years or greater
- Diagnosed with a middle cerebral artery stroke \>1 year ago
- Community-dwelling (i.e. not living in long-term care or other inpatient setting)
- Able to stand independently for 60 seconds
- Able to understand spoken English
You likely can't join if
- Any condition other than stroke that significantly affects their postural control (e.g. vestibular disorder, vision loss)
- A prior lower extremity fragility fracture
- A planned injection of botulinum toxin to the legs during the intervention period
- Peripheral nerve damage in the legs
- Contraindications for electrical stimulation (i.e. implanted electronic device, active cancer or radiation in past six months, uncontrolled epilepsy...
- Contraindications for TMS (i.e. seizures, metal in the head)
See the full eligibility criteria
- Aged 18 years or greater
- Diagnosed with a middle cerebral artery stroke \>1 year ago
- Community-dwelling (i.e. not living in long-term care or other inpatient setting)
- Able to stand independently for 60 seconds
- Able to understand spoken English
- Any condition other than stroke that significantly affects their postural control (e.g. vestibular disorder, vision loss)
- A prior lower extremity fragility fracture
- A planned injection of botulinum toxin to the legs during the intervention period
- Peripheral nerve damage in the legs
- Contraindications for electrical stimulation (i.e. implanted electronic device, active cancer or radiation in past six months, uncontrolled epilepsy, skin rash/wound at an electrode site, pregnancy, active deep vein...
- Contraindications for TMS (i.e. seizures, metal in the head)
- Previous participation in tSCS within the past 2 years (May affect blinding integrity. Likely uncommon; FES is rarely used in Canada post-stroke.)
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.